A Treat-to-Target Strategy with Methotrexate and Intra-Articular Triamcinolone With or Without Adalimumab Effectively Reduces MRI Synovitis, Osteitis and Tenosynovitis and Halts Structural Damage Progression in Early Rheumatoid Arthritis: Results from the OPERA Randomised Controlled Trial

Published:
October 3, 2017

Publication:
Annals of the Rheumatic Diseases

Authors:
Axelsen, M.B., Eshed, I., Hørslev-Petersen, K., Stengaard-Pedersen, K., Hetland, M.L., Møller, J., Junker, P., Pødenphant, J., Schlemmer, A., Ellingsen, T. and Ahlquist, P.

Publications

A Treat-to-Target Strategy with Methotrexate and Intra-Articular Triamcinolone With or Without Adalimumab Effectively Reduces MRI Synovitis, Osteitis and Tenosynovitis and Halts Structural Damage Progression in Early Rheumatoid Arthritis: Results from the OPERA Randomised Controlled Trial

Maecenas tempor, ex at maximus efficitur, felis sem ultrices ligula, ut hendrerit purus eros ac urna. Vestibulum ut vestibulum tortor. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Cras eu lectus quam. Nunc ligula arcu, auctor sit amet tellus eleifend, facilisis laoreet odio. Donec placerat urna eleifend blandit porttitor.

Nunc magna turpis, tristique at dictum vel, sollicitudin blandit felis. Morbi aliquam elit et pellentesque vulputate. Donec elementum, ante quis ornare porttitor, tortor dolor vestibulum velit, et viverra enim massa vitae ex.

Wordpress Meta Data and Taxonomies Filter

18F-FDG PET/CT (10)
Acute Ischemic Stroke (1)
Adenocarcinoma (1)
Adipose Tissue (2)
AI (1)
AI / Machine Learning (3)
Alzheimer’s (9)
amyloid PET (1)
Ankylosing Spondylitis (7)
Arterial Hypertension (1)
Arterial Spin Labelling (3)
Artificial Intelligence (17)
Autism (1)
Auto-Immune & Inflammatory (26)
Autoimmune -TrialSolutions (1)
Back Pain (1)
Bladder cancer (1)
Bone Disease (31)
Bone Marrow Edema (9)
Brain (34)
Breast Cancer (4)
Cardiac (1)
Cardiac Adipose Tissues (1)
Cartilage (38)
Cervical Spine and Skull Base Fractures (2)
Chronic Recurrent Multifocal Osteomyelitis (2)
Clinical Trial Technology (103)
CNS (77)
COVID19 (1)
CT (29)
DCE-CT (12)
DCE-MRI (56)
DECT (11)
Dementia (2)
dGEMRIQ (19)
Diffusion Imaging (21)
Diffusion Kurtosis Imaging (4)
DWI-MRI (21)
Dynamic Perfusion-Weighted MRI (25)
Epilepsy (1)
Erosions (9)
Fibromyalgia (3)
Fracture (1)
Gallbladder cancer (1)
gastroenterology (2)
Gene Expression (5)
Giant Basal Cell Carcinoma (1)
Glioblastoma (34)
Glioma (46)
Gout (1)
Head and Neck Cancer (16)
Hematology (2)
Hepatic Insufficiency (3)
Hepatocellular carcinoma (2)
Imaging Considerations (240)
iMRI (1)
Inflammation (52)
Inflammatory Arthritis (96)
Intracranial Masses (12)
Intracranial Tumors (12)
Juvenile Idiopathic Arthritis (9)
Kidney Cancer (3)
Leukemia (1)
Liver Cancer (6)
Liver disease (3)
Lumbar Spine (2)
Lung Cancer (4)
Lung Disease (4)
Lupus (4)
Machine Learning (17)
Magnetic Transfer Ratio Imaging (3)
Medial Plantar Arch (1)
Meningioma (1)
Mesothelioma (1)
MR-spectroscopy (3)
MRI (147)
MRI/PET (39)
MSI-H cancer (1)
MTR Histogram (3)
Multi-Modality Imaging (17)
Multiple Sclerosis (14)
Musclar Dystrophy (5)
Muscle (16)
Muscle disuse atrophy (2)
Musculoskeletal (254)
Myositis (1)
Nerve Disorders (9)
Neuro-Oncology (80)
Neurology (24)
Neurology -TrialSolutions (1)
Neurosurgical Planning (7)
OCT (2)
Oncology (130)
Ophtalmology -TrialSolutions (1)
Oral Cavity Cancer (1)
Osteoarthrits (92)
Osteonecrosis (1)
Ovarian cancer (1)
Pain (41)
PET (8)
PET/CT (10)
PET/MRI (4)
Pre-clinical (1)
Prostate Cancer (24)
Proteus Syndrome (2)
Psoriasis (3)
Psoriatic arthritis (21)
Radiofrequency Treatment (1)
Radiogenomics (1)
Radiomics (26)
Rare Diseases (10)
Renal Cell Carcinoma (4)
Rheumatoid Arthritis (81)
Rheumatology (54)
Rheumatology -TrialSolutions (2)
Sacroiliitis (4)
Scleroderma (6)
Sinonasal Cancer (1)
Skin (2)
Solid Tumor (63)
Spinal Stenosis (8)
Spine (23)
Spondyloarthritis (2)
Sports Medicine (10)
Squamous Cell Cancer (6)
Synovitis (36)
Tendinopathy (1)
Tendon (3)
Thyroid Cancer (1)
Tractography (1)
Ulcerative Colitis (2)
Ultrasound (1)
Vascular Anomalies (1)
Viral Infection (1)
Weight-bearing MRI (15)
Wound (1)

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

A Treat-to-Target Strategy with Methotrexate and Intra-Articular Triamcinolone With or Without Adalimumab Effectively Reduces MRI Synovitis, Osteitis and Tenosynovitis and Halts Structural Damage Progression in Early Rheumatoid Arthritis: Results from the OPERA Randomised Controlled Trial

A Treat-to-Target Strategy with Methotrexate and Intra-Articular Triamcinolone With or Without Adalimumab Effectively Reduces MRI Synovitis, Osteitis and Tenosynovitis and Halts Structural Damage Progression in Early Rheumatoid Arthritis: Results from the OPERA Randomised Controlled Trial

Wordpress Meta Data and Taxonomies Filter

Categories

Contact Us

A Treat-to-Target Strategy with Methotrexate and Intra-Articular Triamcinolone With or Without Adalimumab Effectively Reduces MRI Synovitis, Osteitis and Tenosynovitis and Halts Structural Damage Progression in Early Rheumatoid Arthritis: Results from the OPERA Randomised Controlled Trial

A Treat-to-Target Strategy with Methotrexate and Intra-Articular Triamcinolone With or Without Adalimumab Effectively Reduces MRI Synovitis, Osteitis and Tenosynovitis and Halts Structural Damage Progression in Early Rheumatoid Arthritis: Results from the OPERA Randomised Controlled Trial

Wordpress Meta Data and Taxonomies Filter

Categories

Contact Us

Important notice regarding use of cookies: